CardioSert is developing a novel Crossing Guide Wire for revascularization of chronic total occluded (CTO) coronary and peripheral arteries.The Crossing Guide Wire has unique features such as: Producing elevated tapping impact on the calcified lesion for ultimate CTO penetration. Steering and redirecting by changing the length and the curvature of the wire’s tip during the operation. Modifying the flexibility and stiffness during the operation without replacing the wire. Allows the usage of commonly used coronary balloons (OTW and monorail).
Founded in October 2008, LunGuard is a device based company engaged in developing a novel Peristaltic Feeding Tube (PFT) catering to hospitalized patients in Intensive Care Units (ICU). The purpose of the PFT is two fold: to act as an improved lumen feeding tube, in addition to being a preventive measure to Ventilator Associated Pneumonia (VAP). VAP is the leading cause of morbidity and mortality in intensive care units (ICU’s) and LunGuard’s innovative PFT device may significantly reduce the incidences of VAP, translating into shorter hospitalization periods, better ICU medical care and reduced mortality cases. LunGuard, backed by the Maayan Venture Technology Incubator, successfully established its proof-of-concept in animal trials and should start first in man trials in November 2010.LunGuard has submitted a PCT application.
Founded in 2008, RapiDx is a device based company developing a next-generation self-use rapid blood diagnostic test for the growing OTC homecare market. RapTest, is designed with an automated technique/platform to extract blood from the fingertip in a less painful manner, while maintaining a blood-free environment. The company has completed developing its first working prototype and is in its final stages of developing the first generation RapTest product. Two patent applications were submitted on the integration concept, one for the mechanism and design of the device (at the national stage) and one regarding the blood extraction and pain reduction via the RapTest’s automated blood extraction technique.
Flometrica develops personal and accurate disposable urine analyzers which provide diagnostics of urine parameters ranging from urine flow to urine chemistry and biology. Flometrica’s analyzers are designed to be used by patients, anywhere, without any professional assistance. Once the analysis has been completed the patient disposes of the analyzer kit and the result is easily provided to the patient’s doctor.